{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:41Z","timestamp":1786119581016,"version":"build-2736575974"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1097\/iio.0b013e3182009916","type":"journal-article","created":{"date-parts":[[2010,12,6]],"date-time":"2010-12-06T10:36:58Z","timestamp":1291631818000},"page":"17-31","source":"Crossref","is-referenced-by-count":5,"title":["Oxygen and Retinopathy of Prematurity"],"prefix":"10.1097","volume":"51","author":[{"given":"Nathan C.","family":"Sears","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Sears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210126","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","article-title":"Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.","volume":"114","author":"Pierce","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R2-2-20210126","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity.","volume":"1","author":"Alon","year":"1995","journal-title":"Nat Med"},{"key":"R3-2-20210126","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10633-009-9197-2","article-title":"Oxygen supply and consumption in the retina: implications for studies of retinopathy of prematurity.","volume":"120","author":"Cringle","year":"2010","journal-title":"Doc Ophthalmol"},{"key":"R4-2-20210126","first-page":"182","article-title":"Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression.","volume":"40","author":"Ozaki","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R5-2-20210126","first-page":"2367","article-title":"Development of astrocytes and their relation to blood vessels in fetal monkey retina.","volume":"37","author":"Gariano","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-2-20210126","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/dvdy.21122","article-title":"Hyperoxia inhibits several critical aspects of vascular development.","volume":"236","author":"Uno","year":"2007","journal-title":"Dev Dyn"},{"key":"R7-2-20210126","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1350-9462(01)00012-X","article-title":"Development of the primate retinal vasculature.","volume":"20","author":"Provis","year":"2001","journal-title":"Prog Retin Eye Res"},{"key":"R8-2-20210126","first-page":"3442","article-title":"Vascular development in primate retina: comparison of laminar plexus formation in monkey and human.","volume":"35","author":"Gariano","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-2-20210126","first-page":"1217","article-title":"Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis.","volume":"41","author":"Hughes","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-2-20210126","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1006\/dbio.1995.1291","article-title":"Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation.","volume":"171","author":"Flamme","year":"1995","journal-title":"Dev Biol"},{"key":"R11-2-20210126","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0002-9394(66)91322-5","article-title":"Oxygen and the growth and development of retinal vessels. In vivo and in vitro studies:: the XX Francis I. Proctor Lecture.","volume":"62","author":"Ashton","year":"1966","journal-title":"Am J Ophthalmol"},{"key":"R12-2-20210126","first-page":"3500","article-title":"Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion.","volume":"43","author":"Dorrell","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-2-20210126","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1113\/jphysiol.1987.sp016859","article-title":"Improvement in human vision under bright light: grain or gain.","volume":"394","author":"Chen","year":"1987","journal-title":"J Physiol"},{"key":"R14-2-20210126","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1167\/iovs.03-1169","article-title":"Astrocyte-endothelial cell relationships during human retinal vascular development.","volume":"45","author":"Chan-Ling","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-2-20210126","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1006\/exer.1997.0365","article-title":"Development of the human retinal vasculature: cellular relations and VEGF expression.","volume":"65","author":"Provis","year":"1997","journal-title":"Exp Eye Res"},{"key":"R16-2-20210126","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0165-3806(88)90118-6","article-title":"Immunocytochemical studies on the development of astrocytes, Muller (glial) cells, and oligodendrocytes in the rabbit retina.","volume":"44","author":"Schnitzer","year":"1988","journal-title":"Brain Res Dev Brain Res"},{"key":"R17-2-20210126","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1113\/expphysiol.2006.033498","article-title":"Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1.","volume":"91","author":"Semenza","year":"2006","journal-title":"Exp Physiol"},{"key":"R18-2-20210126","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1073\/pnas.88.13.5680","article-title":"Hypoxia-inducible nuclear factors bind to an enhancer element located 3 to the human erythropoietin gene.","volume":"88","author":"Semenza","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-2-20210126","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0959-437X(98)80016-6","article-title":"Hypoxia-inducible factor 1: master regulator of O2 homeostasis.","volume":"8","author":"Semenza","year":"1998","journal-title":"Curr Opin Genet Dev"},{"key":"R20-2-20210126","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.","volume":"92","author":"Wang","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-2-20210126","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.1128\/MCB.12.12.5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol Cell Biol"},{"key":"R22-2-20210126","doi-asserted-by":"crossref","first-page":"17771","DOI":"10.1074\/jbc.271.30.17771","article-title":"Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1.","volume":"271","author":"Jiang","year":"1996","journal-title":"J Biol Chem"},{"key":"R23-2-20210126","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"R24-2-20210126","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"R25-2-20210126","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.","volume":"275","author":"Cockman","year":"2000","journal-title":"J Biol Chem"},{"key":"R26-2-20210126","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1073\/pnas.181341498","article-title":"HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation.","volume":"98","author":"Yu","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-2-20210126","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7861\/clinmedicine.6-6-573","article-title":"Understanding hypoxia signalling in cells--a new therapeutic opportunity.","volume":"6","author":"Ratcliffe","year":"2006","journal-title":"Clin Med"},{"key":"R28-2-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2004.04.010","article-title":"Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications.","volume":"17","author":"Brahimi-Horn","year":"2005","journal-title":"Cell Signal"},{"key":"R29-2-20210126","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/S0960-894X(03)00539-0","article-title":"2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.","volume":"13","author":"Mole","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"R30-2-20210126","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0960-894X(03)00149-5","article-title":"Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.","volume":"13","author":"Schlemminger","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"R31-2-20210126","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nchembio863","article-title":"Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one.","volume":"3","author":"Ozer","year":"2007","journal-title":"Nat Chem Biol"},{"key":"R32-2-20210126","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.","volume":"394","author":"Carmeliet","year":"1998","journal-title":"Nature"},{"key":"R33-2-20210126","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrm1366","article-title":"Oxygen sensing by HIF hydroxylases.","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R34-2-20210126","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1068592","article-title":"Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch.","volume":"295","author":"Lando","year":"2002","journal-title":"Science"},{"key":"R35-2-20210126","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1101\/gad.991402","article-title":"FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.","volume":"16","author":"Lando","year":"2002","journal-title":"Genes Dev"},{"key":"R36-2-20210126","doi-asserted-by":"crossref","first-page":"26351","DOI":"10.1074\/jbc.C200273200","article-title":"Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family.","volume":"277","author":"Hewitson","year":"2002","journal-title":"J Biol Chem"},{"key":"R37-2-20210126","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/emboj\/cdg117","article-title":"HLFHIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin.","volume":"22","author":"Morita","year":"2003","journal-title":"EMBO J"},{"key":"R38-2-20210126","doi-asserted-by":"crossref","first-page":"e11103","DOI":"10.1371\/journal.pone.0011103","article-title":"HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia.","volume":"5","author":"Mowat","year":"2010","journal-title":"PLoS One"},{"key":"R39-2-20210126","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/cdd.2008.10","article-title":"Role and regulation of prolyl hydroxylase domain proteins.","volume":"15","author":"Fong","year":"2008","journal-title":"Cell Death Differ"},{"key":"R40-2-20210126","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF.","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"R41-2-20210126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"R42-2-20210126","doi-asserted-by":"crossref","first-page":"30544","DOI":"10.1074\/jbc.M704988200","article-title":"An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha.","volume":"282","author":"Koivunen","year":"2007","journal-title":"J Biol Chem"},{"key":"R43-2-20210126","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1182\/blood-2007-09-114561","article-title":"Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins.","volume":"111","author":"Takeda","year":"2008","journal-title":"Blood"},{"key":"R44-2-20210126","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.107.701516","article-title":"Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.","volume":"116","author":"Takeda","year":"2007","journal-title":"Circulation"},{"key":"R45-2-20210126","first-page":"262","article-title":"Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II. Report of cases-clinical aspects.","volume":"40","author":"Terry","year":"1942","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R46-2-20210126","first-page":"18","article-title":"Retrolental fibroplasia in premature infants.","volume":"53","author":"Owens","year":"1948","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"R47-2-20210126","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jama.1949.02900260018005","article-title":"Retrolental fibroplasia; incidence in different localities in recent years and a correlation of the incidence with treatment given the infants.","volume":"139","author":"Kinsey","year":"1949","journal-title":"J Am Med Assoc"},{"key":"R48-2-20210126","first-page":"724","article-title":"Fibrosis of posterior vascular sheath of lens.","volume":"41","author":"Galloway","year":"1948","journal-title":"Proc R Soc Med"},{"key":"R49-2-20210126","first-page":"235","article-title":"Retrolental fibroplasia occurring in twins.","volume":"43","author":"Martin","year":"1950","journal-title":"Proc R Soc Med"},{"key":"R50-2-20210126","first-page":"235","article-title":"Retrolental fibroplasia in a premature baby.","volume":"43","author":"Franklin","year":"1950","journal-title":"Proc R Soc Med"},{"key":"R51-2-20210126","first-page":"32","article-title":"Retrolental fibroplasia.","volume":"21","author":"Crosse","year":"1952","journal-title":"Ulster Med J"},{"key":"R52-2-20210126","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5694\/j.1326-5377.1951.tb109040.x","article-title":"Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach.","volume":"2","author":"Campbell","year":"1951","journal-title":"Med J Aust"},{"key":"R53-2-20210126","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0002-9394(52)90003-2","article-title":"Retrolental fibroplasia; a clinicopathologic study.","volume":"35","author":"Ryan","year":"1952","journal-title":"Am J Ophthalmol"},{"key":"R54-2-20210126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/archopht.1952.00920010086012","article-title":"Prevention of retrolental fibroplasia.","volume":"48","author":"Crosse","year":"1952","journal-title":"AMA Arch Ophthalmol"},{"key":"R55-2-20210126","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9394(52)91140-9","article-title":"Studies on the effect of high oxygen administration in retrolental fibroplasias. I. Nursery observations.","volume":"35","author":"Patz","year":"1952","journal-title":"Am J Ophthalmol"},{"key":"R56-2-20210126","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0161-6420(79)35330-1","article-title":"The pathogenesis of retrolental fibroplasia.","volume":"86","author":"Ashton","year":"1979","journal-title":"Ophthalmology"},{"key":"R57-2-20210126","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archopht.1956.00930040489001","article-title":"Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen.","volume":"56","author":"Kinsey","year":"1956","journal-title":"AMA Arch Ophthalmol"},{"key":"R58-2-20210126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10633-009-9181-x","article-title":"The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 5010 OIR model.","volume":"120","author":"Hartnett","year":"2010","journal-title":"Doc Ophthalmol"},{"key":"R59-2-20210126","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1203\/01.PDR.0000099772.66376.02","article-title":"Hypoxic oxygen fluctuations produce less severe retinopathy than hyperoxic fluctuations in a rat model of retinopathy of prematurity.","volume":"55","author":"McColm","year":"2004","journal-title":"Pediatr Res"},{"key":"R60-2-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpeds.2010.01.046","article-title":"A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity.","volume":"157","author":"Di Fiore","year":"2010","journal-title":"J Pediatr"},{"key":"R63-2-20210126","first-page":"78","article-title":"A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity.","volume":"104","author":"Wright","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R64-2-20210126","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ophtha.2008.09.051","article-title":"A change in oxygen supplementation can decrease the incidence of retinopathy of prematurity.","volume":"116","author":"Sears","year":"2009","journal-title":"Ophthalmology"},{"key":"R65-2-20210126","doi-asserted-by":"crossref","first-page":"e1483","DOI":"10.1542\/peds.2009-2218","article-title":"High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis.","volume":"125","author":"Chen","year":"2010","journal-title":"Pediatrics"},{"key":"R66-2-20210126","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1073\/pnas.90.9.4304","article-title":"General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.","volume":"90","author":"Wang","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R67-2-20210126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/scdb.2001.0287","article-title":"Oxygen sensors and angiogenesis.","volume":"13","author":"Maxwell","year":"2002","journal-title":"Semin Cell Dev Biol"},{"key":"R68-2-20210126","first-page":"526","article-title":"Erythropoietin deficiency decreases vascular stability in mice.","volume":"118","author":"Chen","year":"2008","journal-title":"J Clin Invest"},{"key":"R69-2-20210126","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1073\/pnas.0702031104","article-title":"IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.","volume":"104","author":"Lofqvist","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R70-2-20210126","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1167\/iovs.03-0565","article-title":"IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line D407.","volume":"45","author":"Slomiany","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R71-2-20210126","doi-asserted-by":"crossref","first-page":"19898","DOI":"10.1073\/pnas.0805817105","article-title":"Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy.","volume":"105","author":"Sears","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R72-2-20210126","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.siny.2010.05.006","article-title":"Hypoxia-inducible factor (HIF) and HIF-stabilizing agents in neonatal care.","volume":"15","author":"Park","year":"2010","journal-title":"Semin Fetal Neonatal Med"}],"container-title":["International Ophthalmology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IIO.0b013e3182009916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:37:45Z","timestamp":1786041465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004397-201105110-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/iio.0b013e3182009916","relation":{},"ISSN":["0020-8167"],"issn-type":[{"value":"0020-8167","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}